Grants for Native American tribal organizations - Health

This funding opportunity supports innovative research into the biology and mechanisms of bladder cancer, particularly focusing on non-muscle-invasive bladder cancer, to improve understanding and develop new prevention or treatment strategies.

The purpose of this program is to expand substance use disorder (SUD) treatment and recovery support services in existing drug courts. The program recognizes the need for treatment instead of incarceration for individuals with SUDs. Recipients are expected to provide prevention, harm reduction, treatment, and recovery services for individuals with SUD involved with the courts. With this program, SAMHSA aims to improve abstinence from substance use, housing stability, employment status, social connectedness, health/behavioral/social consequences, and reduce criminal justice involvement. Eligible applicants include States and Territories, political subdivisions of States, drug courts, Indian tribes or tribal organizations, health facilities, or programs operated by or in accordance with a contract or award with the Indian Health Service, or other public or private nonprofit entities. Applications are due by April 1, 2024. The anticipated award amount is up to $400,000 per year for up to 5 years.

This grant provides funding for research projects aimed at understanding and improving diagnostic safety in outpatient healthcare settings across the United States, targeting diverse environments such as urgent care and telehealth.

This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biological/genetic bases of cancer health disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.

This funding opportunity provides financial support to a wide range of organizations, including universities, governments, and nonprofits, to modernize and enhance the national system for tracking eye health data and addressing disparities in vision care across the U.S.

This funding opportunity supports U.S.-based organizations in hosting conferences and workshops that promote research and dialogue on improving workplace safety and health across various industries.

This grant provides financial support to NIMH tenure-track researchers transitioning to independent faculty positions, enabling them to establish their own mental health research programs at external institutions.

The purpose of this Notice of Funding Opportunity (NOFO) is to support proof-of-concept feasibility trials guided by the NIH Music-based Interventions (MBI) Toolkit for research on brain disorders of aging. These early phase clinical trials will generate evidence supporting the validity of the NIH MBI Toolkits guiding principles as well as the necessary pilot data to design a subsequent clinical efficacy or effectiveness study (or pragmatic clinical trial) using music-based interventions in the context of brain disorders of aging, including but not limited to Alzheimers disease and Alzheimers disease-related dementias, Parkinsons disease, and stroke. The data collected should address gaps in scientific knowledge in order to facilitate development of a competitive large-scale clinical trial.

Not Available

This funding opportunity supports researchers investigating the biological and genetic factors contributing to cancer health disparities, aiming to foster a network of experts in this critical area of study.

The purpose of this Alzheimers Disease-Related Dementia (ADRD) initiative is to promote the development and distribution of innovative technologies, methods, protocols, and biomedical materials that enhance combined human neuropathology and neuroimaging research with data aimed at understanding the underlying pathophysiology of in vivo imaging results typically associated with vascular contributions to cognitive impairment and dementia (VCID) in TBI-related dementia and other ADRD diagnoses. Resources developed under this FOA must follow open data sharing practices and are intended to expand the broader research communitys capacity to perform research aimed at neuropathologically-informed understanding of the vascular pathophysiology of clinically-relevant, in vivo neuroimaging findings.Letter of Intent Due Date(s) Not Applicable

This funding opportunity supports early-stage researchers in the U.S. to develop expertise in using nonhuman primate models for biomedical research, with a focus on infectious diseases, neuroscience, and aging, through a structured mentorship program.

Through this funding opportunity announcement, the National Cancer Institute (NCI) solicits applications to Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts PAR. This funding opportunity announcement seeks to support initiating and building the next generation of population-based cancer epidemiology cohorts to address specific knowledge gaps in cancer etiology and survivorship. Specifically, it will support methodological work necessary to initiate and build cancer epidemiology cohorts that can address critical scientific gaps concerning (i) new or unique exposures in relation to cancer risks and outcomes and (ii) achievement of diverse populations in cohorts with the inclusion of understudied populations (e.g., racial/ethnic groups, rural populations, and persistent poverty areas) with substantial community engagement.

The ITP ASH 2024 grant initiative, offered by SANOFI, is designed to identify and fund projects that aim to close significant healthcare gaps related to the treatment and management of Immune Thrombocytopenia (ITP). ITP is a rare blood disorder characterized by a significantly reduced platelet count, leading to a heightened risk of bleeding and serious health complications such as thrombosis and hematologic malignancy. The chronic nature of ITP often results in a diminished quality of life for patients, manifesting in anxiety, fatigue, and depression due to ongoing concerns about bleeding risks and ineffective current therapies. SANOFI is particularly interested in supporting educational and therapeutic strategies that promise to enhance the clinical handling of ITP, focusing on innovative treatment methodologies and educational activities that can lead to improved patient outcomes. Proposals are invited for projects including, but not limited to, live symposiums at medical conferences, enduring materials for broader educational reach, and both accredited and non-accredited Independent Medical Education (IME) activities. A budget cap of $425,000 is set for the grant, with a strong preference for proposals that incorporate evidence-based approaches and demonstrate potential to address knowledge gaps among healthcare providers, thus improving treatment practices.

This grant provides funding for researchers to investigate how aging affects walking mechanics and increases the energy cost of walking, encouraging innovative studies that combine various scientific disciplines and technologies.

The Tier 1 Local Projects under the 2023 Outdoor Recreation Trails+ Grant aim to support conservation-oriented, shovel-ready projects that benefit specific communities. These projects must be publicly accessible and demonstrate economic benefits through improved quality of life, public health outcomes, and eco-tourism. Eligible applicants include Tribes, Pueblos, Nations, municipalities, counties, public schools, colleges, soil and water conservation districts, and land grant associations. Nonprofits are not eligible. Projects must be completed within 24 months, with grants awarded up front and applications accepted on a rolling basis starting July 1, 2023 until funds are expended or June 30th 2024 (for FY24)

The purpose of this notice of funding opportunity (NOFO) is to solicit applications proposing mechanistic transdisciplinary research in animal models that integrates approaches across social/cognitive neuroscience with perspectives from fields with complementary approaches to the study of social behavior, with the goal of developing a testable conceptual or computational model that provides mechanistic insights into social behavior and its relationships with the onset, trajectory and impact of Substance Use Disorders (SUD) and comorbidities. This NOFO is intended to support basic or translational research in non-human animal models, including secondary analysis of data from research in animal models. Applications including studies involving human subjects should submit under one of the companion NOFOs.

The purpose of the SAP program is to advance equity in health outcomes for racial and ethnic minority communities, especially all Black female identities, including cisgender, transgender, nonbinary, and genderqueer/fluid individuals in the South who are experiencing disparities related to HIV/AIDS, viral hepatitis (VH), sexually transmitted infections (STIs), substance use and substance use disorders (SUDs), and/or mental health conditions.

The overarching goal of the supported research projects will be to determine neural and cognitive mechanisms that underlie the relationship between social cognition/behavior and the SUD trajectory. The purpose of this notice of funding opportunity (NOFO) is to solicit applications proposing mechanistic, transdisciplinary research on social behavior and its relationships with the onset, trajectory, and impact of Substance Use Disorders (SUDs) and comorbidities. This NOFO is intended to support basic or early translational studies that may, but need not, be considered NIH clinical trials; this may include mechanistic clinical trials, observational studies, or secondary analysis of human data. Clinical trials supported by this funding opportunity are limited to mechanistic clinical trials. A mechanistic clinical trial is designed to understand a biological or behavioral process, the pathophysiology of a disease, biomarkers for a disease or response to treatment, or the mechanism of action of an intervention. It is not designed to test the safety or demonstrate the efficacy/effectiveness of an intervention. This NOFO is not intended to support studies designed to test the safety or demonstrate the efficacy of an intervention. Application budgets are not limited but need to reflect the actual needs of the proposed project.

This grant provides funding for multidisciplinary teams to develop and advance innovative therapies and medical devices aimed at treating visual system diseases, with the goal of preparing them for FDA approval and clinical trials.